In the present study, we show that sAβPPβ used in combination with NFL has a high ability to distinguish SSVD from healthy controls and that the addition of sAβPPβ to the core AD biomarkers improves the separation of SSVD from AD and mixed dementia. Here, NEFL is linked to Alzheimer disease.